drugset / Trial / NCT00963664
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether an outpatient combination of lovastatin and low-to-moderate dose interferon is effective in the treatment of patients with malignant melanoma.
Timeline
- Start
- 2009-12
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | 1.5 mg/kg | Oral |
| Subject | interferon alfa-2b | Protein / enzyme biologic | 100000 iu/kg | Subcutaneous |